We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is BAVARIAN NORDIC (BVNRY) Outperforming Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has BAVARIAN NORDIC (BVNRY - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
BAVARIAN NORDIC is a member of the Medical sector. This group includes 887 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. BVNRY is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for BVNRY's full-year earnings has moved 7.41% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BVNRY has moved about 22.90% on a year-to-date basis. Meanwhile, stocks in the Medical group have lost about 1.63% on average. This means that BAVARIAN NORDIC is performing better than its sector in terms of year-to-date returns.
To break things down more, BVNRY belongs to the Medical - Biomedical and Genetics industry, a group that includes 381 individual companies and currently sits at #39 in the Zacks Industry Rank. On average, stocks in this group have gained 8.58% this year, meaning that BVNRY is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track BVNRY. The stock will be looking to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is BAVARIAN NORDIC (BVNRY) Outperforming Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has BAVARIAN NORDIC (BVNRY - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
BAVARIAN NORDIC is a member of the Medical sector. This group includes 887 individual stocks and currently holds a Zacks Sector Rank of #1. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. BVNRY is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for BVNRY's full-year earnings has moved 7.41% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BVNRY has moved about 22.90% on a year-to-date basis. Meanwhile, stocks in the Medical group have lost about 1.63% on average. This means that BAVARIAN NORDIC is performing better than its sector in terms of year-to-date returns.
To break things down more, BVNRY belongs to the Medical - Biomedical and Genetics industry, a group that includes 381 individual companies and currently sits at #39 in the Zacks Industry Rank. On average, stocks in this group have gained 8.58% this year, meaning that BVNRY is performing better in terms of year-to-date returns.
Investors with an interest in Medical stocks should continue to track BVNRY. The stock will be looking to continue its solid performance.